Zydus Pharmaceuticals (USA) Inc., a subsidiary of Ahmedabad-based Zydus Lifesciences, has initiated a voluntary recall of 8,784 bottles of its liver infection treatment, Entecavir, from the U.S. market.
Entecavir Batches In USA | 10/10/2025 | By Darshana | 222
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy